SignatureFD
DYN icon

SignatureFD’s Dyne Therapeutics DYN Stock Holding History

SignatureFD’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.48K Sell
278
-142
-34% -$3.26K ﹤0.01% 2969
2026
Q2 		$9.33K Buy
420
+142
+51% +$2.64K ﹤0.01% 2664
2026
Q1 		$5.04K Sell
278
-42
-13% -$724 ﹤0.01% 2781
2025
Q4 		$6.26K Buy
320
+42
+15% +$795 ﹤0.01% 2604
2025
Q3 		$3.52K Sell
278
-12
-4% -$137 ﹤0.01% 2784
2025
Q2 		$2.76K Sell
290
-441
-60% -$4.86K ﹤0.01% 2786
2025
Q1 		$7.65K Buy
731
+133
+22% +$1.9K ﹤0.01% 2460
2024
Q4 		$14.1K Sell
598
-99
-14% -$2.93K ﹤0.01% 2231
2024
Q3 		$25K Buy
697
+58
+9% +$2.31K ﹤0.01% 1930
2024
Q2 		$22.6K Buy
639
+41
+7% +$1.19K ﹤0.01% 1901
2024
Q1 		$17K Buy
598
+19
+3% +$430 ﹤0.01% 2079
2023
Q4 		$7.7K Buy
579
+468
+422% +$4.57K ﹤0.01% 2365
2023
Q3 		$995 Sell
111
-103
-48% -$1.11K ﹤0.01% 2938
2023
Q2 		$2.41K Buy
214
+23
+12% +$271 ﹤0.01% 2751
2023
Q1 		$2.2K Hold
191
– – ﹤0.01% 2776
2022
Q4 		$2.21K Hold
191
– – ﹤0.01% 2784
2022
Q3 		$2K Buy
+191
New +$2.19K ﹤0.01% 2760
2022
Q2 		– Sell
-71
Closed -$1K – 3161
2022
Q1 		$1K Buy
+71
New +$604 ﹤0.01% 2971
2021
Q4 		– Sell
-49
Closed -$1K – 3142
2021
Q3 		$1K Buy
+49
New +$869 ﹤0.01% 2809

Other funds holding DYN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors Cambridge, Massachusetts $631M AUM 38.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

SignatureFD's DYN Position: Q3 2026 in Review

SignatureFD reduced its Dyne Therapeutics (DYN) stake by 34% in Q3 2026, selling an estimated $3.26K and leaving 278 shares worth $4.48K. The position accounts for ﹤0.01% of the portfolio, ranked #2969.

SignatureFD first reported a position in DYN in Q3 2021 and has held it in 19 quarters since. The position peaked at $25K in Q3 2024. 109 funds tracked by Wall St. Rank hold DYN as of Q3 2026.

  • SignatureFD held 278 shares of Dyne Therapeutics worth $4.48K as of Q3 2026.
  • SignatureFD sold 142 Dyne Therapeutics shares in Q3 2026, an estimated $3.26K.
  • Dyne Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2969 holding.
  • SignatureFD first reported a position in Dyne Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • SignatureFD's Dyne Therapeutics position peaked at $25K in Q3 2024.
  • 109 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.